Showing results (1-10 of 503) with videos related to
Sort By:
Pageof 51
Clinical Lymphoma, Myeloma & Leukemia|December 10, 2014
The road to treating smoldering multiple myelomaNeha Korde, Sham Mailankody, Ola LandgrenClinical Advances in Hematology & Oncology : H&O|February 6, 2015
Smoldering multiple myeloma: pathophysiologic insights, novel diagnostics, clinical risk models, and treatment strategiesDickran Kazandjian, Sham Mailankody, Neha Korde, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2014
Dilemmas in treating smoldering multiple myelomaInhye E Ahn, Sham Mailankody, Neha Korde, et al.Blood|February 8, 2012
Second malignancies after multiple myeloma: from 1960s to 2010sAnish Thomas, Sham Mailankody, Neha Korde, et al.Best Practice & Research. Clinical Haematology|November 10, 2016
Monoclonal gammopathy of undetermined significance and Waldenström's macroglobulinemiaSham Mailankody, Ola LandgrenNature Reviews. Clinical Oncology|January 28, 2015
Minimal residual disease in multiple myeloma: bringing the bench to the bedsideSham Mailankody, Neha Korde, Alexander M Lesokhin, et al.European Journal of Haematology|October 12, 2013
Smoldering multiple myeloma: present position and potential promisesNishant Tageja, Elisabet E Manasanch, Neha Korde, et al.Blood|July 29, 2011
Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS)Sham Mailankody, Ruth M Pfeiffer, Sigurdur Y Kristinsson, et al.Cancer Chemotherapy and Pharmacology|May 11, 2017
Carfilzomib and lenalidomide response related to VEGF and VEGFR2 germline polymorphismsTristan M Sissung, Cody J Peer, Neha Korde, et al.Pageof 51